SCHEMBL648606

SCHEMBL648606

CCOC(=O)/C=C/c1ccc(C(C)C)cc1C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.50
TTR P02766 1/20 0.46
DPP4 P27487 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
ESR1 P03372 1/20 0.45
CYP3A4 P08684 2/20 0.44
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
MAOB P27338 1/20 0.42
FDPS P14324 1/20 0.40
P2RY12 Q9H244 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
MDM4 O15151 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15514 1.00 TYR (0.50) TYRTTRDPP4CA12CA1
SCHEMBL7183094 0.90 TYR (0.48) TYRTTRDPP4CA12CA1
SCHEMBL29693828 0.90 TYR (0.48) TYRTTRDPP4CA12CA1
SCHEMBL14342903 0.90 TYR (0.48) TYRTTRDPP4CA12CA1
Ethyl Cinnamate SCHEMBL28948990 0.89 KDM4E (0.48) TYRTTRDPP4CA12CA1
Ethyl Cinnamate SCHEMBL28948991 0.89 KDM4E (0.48) TYRTTRDPP4CA12CA1
Isopropyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28558517 0.89 CA12 (0.48) TYRTTRDPP4CA12CA1
SCHEMBL645927 0.84 ALDH1A1 (0.48) TYRTTRCA12CA1CA2
SCHEMBL157462 0.84 ALDH1A1 (0.48) TYRTTRCA12CA1CA2
SCHEMBL29435132 0.84 ALDH1A1 (0.48) TYRTTRCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055665-A1 DELIVERY CARRIER INTO CELL ITO, KABUSIKIKAISYA (JP) 2023-02-23 US claimed
CN-101282708-B External preparation for skin containing a phosphorlated saccharide EZAKI GLICO CO 2013-03-20 CN claimed
US-8168227-B2 Modified powder and cosmetic composition using the same SHISEIDO CO., LTD. (JP) 2012-05-01 US claimed
US-20070253989-A1 Modified Powder and Cosmetic Composition Using the Same SHISEIDO CO., LTD. (JP) 2007-11-01 US claimed
US-12564549-B2 Cleanser composition SHISEIDO COMPANY, LTD. (JP) 2026-03-03 US disclosed
US-20250295566-A1 DIESTER HAIR STYLING FORMULATIONS, AND USES THEREOF Chembeau LLC 2025-09-25 US disclosed
US-20250248913-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF Chembeau LLC 2025-08-07 US disclosed
US-20250177270-A1 DIESTER COSMETIC FORMULATIONS AND USES THEREOF Chembeau LLC 2025-06-05 US disclosed
US-12285508-B2 Hair treatment formulations and uses thereof Chembeau LLC (US) 2025-04-29 US disclosed
US-12214065-B2 Diester cosmetic formulations and uses thereof Chembeau LLC (US) 2025-02-04 US disclosed
US-12059489-B2 Oil-in-water type dermatological composition for external use SHISEIDO COMPANY, LTD. (JP) 2024-08-13 US disclosed
CN-113164433-B Oily moisturizer and external composition for skin containing same 日清奥利友集团株式会社 2024-07-09 CN disclosed
EP-0814758-A1 ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS Kao Corporation (JP) 1998-01-07 EP disclosed
WO-1996028137-A1 ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS KAO CORPORATION (JP) 1996-09-19 WO disclosed
EP-0721484-A1 ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS Kao Corporation (JP) 1996-07-17 EP disclosed
EP-0688559-A1 Skin anti-ageing composition SHISEIDO COMPANY LIMITED (JP) 1995-12-27 EP disclosed
US-5427771-A Stable dispersion in cosmetically acceptable vehicle with adjuvants L'OREAL (FR) 1995-06-27 US disclosed
WO-1995009895-A1 ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS KAO CORPORATION (JP) 1995-04-13 WO disclosed
US-5000937-A Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation L'OREAL (FR) 1991-03-19 US disclosed
EP-0211183-A2 Use of ubidecarenone(ubiquinone-10) as an antichromatotic agent Eisai Co., Ltd. (JP) 1987-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12214065-B2 Diester cosmetic formulations and uses thereof DAGLA, CYP19A1, CYP51A1 TYR 17/4885TTR 2293/4885DPP4 3292/4885
US-20250295566-A1 DIESTER HAIR STYLING FORMULATIONS, AND USES THEREOF SUCLG1, SMS, SRM TYR 93/4885TTR 1430/4885DPP4 4453/4885
US-20230055665-A1 DELIVERY CARRIER INTO CELL CTSA, ATG4A, ATG7 TYR 3775/4885TTR 4774/4885DPP4 539/4885
US-12564549-B2 Cleanser composition LIPA, SGMS1, SGMS2 TYR 4713/4885TTR 1002/4885DPP4 4589/4885
US-20250248913-A1 HAIR TREATMENT FORMULATIONS AND USES THEREOF FHIT, SUCLG1, TES TYR 4/4885TTR 1861/4885DPP4 4367/4885
US-12285508-B2 Hair treatment formulations and uses thereof FHIT, SUCLG1, TES TYR 4/4885TTR 1861/4885DPP4 4367/4885
US-20250177270-A1 DIESTER COSMETIC FORMULATIONS AND USES THEREOF DAGLA, CYP19A1, CYP51A1 TYR 17/4885TTR 2293/4885DPP4 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.